A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding

Endoscopy

Volumn 39, Issue 8, 2007, Pages 679-685

  Lo, G H ^a   Liang, H L ^a   Chen, W C ^a   Chen, M H ^a   Lai, K H ^a   Hsu, P I ^a   Lin, C K ^a   Chan, H H ^a   Pan, H B ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENBUCRILATE; IODINATED POPPYSEED OIL; CYANOACRYLATE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRESSURE GRADIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; STENT; STOMACH HEMORRHAGE; STOMACH VARICES; SURVIVAL; AGE; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PROBABILITY; SCLEROTHERAPY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; CYANOACRYLATES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SCLEROTHERAPY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34548014810     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-966591     Document Type: Article

References (35)

1. Groszmann RJ, de Franchis R. Portal hypertension. In: Schiff EF, Sorrell MF, Maddrey WC (eds). Schiff's diseases of the liver. Philadelphia: Lippincott-Raven, 1998: 387-442
2. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004; 126: 1175-1189
3. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32: 264-268
4. Gimson AES, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal hemorrhage. J Hepatol 1991; 13: 274-278
5. Williams SGJ, Peters RA, Westaby D. Thrombin - an effective treatment for gastric variceal hemorrhage. Gut 1994; 35: 1287-1289
6. Lo GH, Lai KH, Cheng JS et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060-1064
7. Lo GH, Lai KH. Is detachable snare really safe and effective for large gastric varices? Gastrointest Endosc 2003: 57: 438-439
8. Soehendra N, Nam VC, Grimm H, Kempeneers I. Endoscopic obliteration of large esophagogastric varices with bucrylate. Endoscopy 1986; 18: 25-26
9. Ramond MJ, Valla D, Mosnier JF et al. Successful endoscopic obliteration of gastric varices with butyl cyanoacrylate. Hepatology 1989; 10: 488-493
10. Huang YH, Yeh HZ, Chen GH et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000; 52: 160-167
11. Chau TN, Patch D, Chan YW et al. Salvage transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-987
12. Stanley AJ, Jalan, Ireland HM et al. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic protosystemic stent shunt (TIPSS). Aliment Pharm Ther 1997; 11: 171-176
13. Barange K, Peron JM, Imani K et al. Transjugular intrahepatic protosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30: 1139-1143
14. Tripathi D, Therapondos G, Jackson E et al. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and hemodynamic correlations. Gut 2002; 51: 270-274
15. Matsumoto A, Kitamoto M, Imamura M et al. Three-dimensional portography using multislice helical CT is clinically useful for management of gastric fundal varices. Am J Roentgenol 2001; 176: 899-905
16. Thomas PG, D'Cruz AJ. Distal splenorenal shunting for bleeding gastric varices. Br J Surg 1994; 81: 241-244
17. Pugh RNN, Murray-Lyon IM, Dawson JI, et al. Transection of esophagus for bleeding esophageal varices. Br J Surg 1973: 60: 646-649
18. Satin SK, Lahoti D, Saxena SP et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-1349
19. Bass NM, Yao FY. Portal hypertension and variceal bleeding. In: Feldman M, Friedman LS, Sleisenger MH (eds). Sleisenger and Fordtran's gastrointestinal and liver disease. 7th edn. Philadelphia: Saunders, 2002: 1487-1515
20. Lo GH, Lai KH, Cheng JS et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 1995; 22: 466-471
21. Sarin SK, Govil A, Jain AK et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal rcurrence. J Hepatol 1997; 26: 826-832
22. Lo GH, Chen WC, Chen MH et al. Endoscopic ligation versus nadolol in the prophylaxis of first variceal bleeding in cirrhosis. Gastrointest Endosc 2004; 59: 333-338
23. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002; 97: 1010-1015
24. Binmoeller KF, Soehendra N. "Superglue": the answer to variceal bleeding and fundal varices? Endoscopy 1995; 27: 392-396
25. Greenwald BD, Caldwell SH, Hespenheide EE et al. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol 2003; 98: 1982-1988
26. Papatheodoridis G, Goulis J, Leandro G et al. Transjugular intrahepatic portosystemic sunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999; 30: 612-622
27. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386-400
28. Spahr L, Dufresne MP, Bui BT et al. Efficacy of TIPS in the prevention of rebleeding from esophageal and fundal varices: a comparative study [abstract]. Hepatology 1995; 22: 296A
29. Sarin SK, Primignani M, Agarwal SR. Gastric varices. In: de Franchis R (eds). Portal hypertension III, Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science, 2001: 76-94
30. Sanyal AJ, Freedman AM, Luketic VA et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889-898
31. Owens CA, Bartolone C, Warner DL et al. The inaccuracy of Duplex ultrasonography in predicting patency of transjugular intrahepatic protosystemic shunts. Gastroenterology 1998; 114: 975-980
32. Lo GH, Lai KH. Should GOV1 be treated as for esophageal varices. Gastroenterology 2004: 127: 1014-1015
33. Lo GH, Lai KH, Shen MT, Chang CF. A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 1994; 40: 675-679
34. Wahl P, Lammer F, Conen D et al. Septic complications after injection of n-butyl-2-cyanoacrylate: report of two cases and review. Gastrointest Endosc 2004; 59: 911-916
35. Angermayr B, Cejna M, Koenig F et al. Survival in patients undergoing transjugular intrahepatic protosystemic shunt: ePTFE-covered stent grafts versus bare stents. Hepatology 2003; 38: 1043-1050